These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 136966)

  • 1. Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.
    Kolbe H; Keller K; Lange K; Herken H
    Biochem Biophys Res Commun; 1976 Nov; 73(2):378-82. PubMed ID: 136966
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
    Davis LH; Kauffman FC
    Neurochem Res; 1987 Jun; 12(6):521-7. PubMed ID: 2955240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6-aminonicotinamide on pentose cycle activity in isolated hepatocytes.
    Carmona A; Freedland RA
    Int J Biochem; 1990; 22(6):595-9. PubMed ID: 2143150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of carbohydrate metabolism in rat kidney after pharmacological blockade of the pentose phosphate pathway.
    Kolbe H; Keller K; Lange K; Herken H
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(1):93-102. PubMed ID: 4256398
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 6-aminonicotinamide blockade of the pentose phosphate pathway on catecholamines in the rat adrenal medulla, superior cervical ganglion, hypothalamus and synaptosome fractions.
    Jansson SE; Gripenberg J; Härkönen M
    Acta Physiol Scand; 1977 Apr; 99(4):467-75. PubMed ID: 140588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the pentose phosphate shunt in thyrotropin-induced thyroid hormone secretion: in vivo and vitro studies with 6-aminonicotinamide in mouse thyroids.
    Hashizume K; Onaya T; Sato A
    Endocrinology; 1975 Oct; 97(4):962-8. PubMed ID: 172320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of utilization of glucose via hexosemonophosphate shunt in brain.
    Gaitonde MK; Evison E; Evans GM
    J Neurochem; 1983 Nov; 41(5):1253-60. PubMed ID: 6619864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in vivo quantitation of the pentose phosphate pathway in brain.
    Hakim AM; Moss G
    Trans N Y Acad Sci; 1972 Jun; 34(6):473-90. PubMed ID: 4504581
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
    Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.
    Gaitonde MK; Lewis LP; Evans G; Clapp A
    Neurochem Res; 1981 Oct; 6(10):1159-67. PubMed ID: 6121299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of the L-type pentose phosphate cycle with [2-14C]glucose and [5-14C]glucose in isolated hepatocytes.
    Longenecker JP; Williams JF
    Biochem J; 1980 Jun; 188(3):859-65. PubMed ID: 7470039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells.
    Keller K; Kolbe H; Herken H; Lange K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):213-5. PubMed ID: 138094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.
    Gaitonde MK; Evans GM
    Neurochem Res; 1982 Sep; 7(9):1163-79. PubMed ID: 6217428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide.
    Herken H; Lange K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):496-9. PubMed ID: 4389238
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative pathways of glucose utilization in brain; changes in the pattern of glucose utilization in brain resulting from treatment of rats with 6-aminonicotinamide.
    Hothersall JS; Zubairu S; McLean P; Greenbaum AL
    J Neurochem; 1981 Dec; 37(6):1484-96. PubMed ID: 6460850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship and control of glucose metabolism and lipogenesis in isolated fat-cells. Control of pentose phosphate-cycle activity by cellular requirement for reduced nicotinamide adenine dinucleotide phosphate.
    Kather H; Rivera M; Brand K
    Biochem J; 1972 Aug; 128(5):1097-102. PubMed ID: 4404963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
    Herken H; Meyer-Estorf G; Halbhübner K; Loos D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):245-55. PubMed ID: 134291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hypoxia on the pentose phosphate pathway in brain.
    Hakim AM; Moss G; Gollomp SM
    J Neurochem; 1976 Apr; 26(4):683-8. PubMed ID: 965959
    [No Abstract]   [Full Text] [Related]  

  • 19. Pentose phosphate shunt and gastric acid secretion in the rat.
    Sernka TJ; Harris JB
    Am J Physiol; 1972 Jan; 222(1):25-32. PubMed ID: 4400690
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of glucose into glutamate via the hexose monophosphate shunt and its inhibition by 6-aminonicotinamide in rat brain in vivo.
    Gaitonde MK; Jones J; Evans G
    Proc R Soc Lond B Biol Sci; 1987 Jun; 231(1262):71-90. PubMed ID: 2888118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.